References
- 1Wong CX, Brown A, Lau DH, Chugh SS, Albert CM, Kalman JM, et al. Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives. Heart Lung Circ. 2019; 28(1):6–14. DOI: 10.1016/j.hlc.2018.08.026
- 2Morin DP, Homoud MK, Estes NAM
3rd. . Prediction and Prevention of Sudden Cardiac Death. Card Electrophysiol Clin. 2017; 9(4):631–638. DOI: 10.1016/j.ccep.2017.07.012 - 3Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000; 21(24):2071–2078. DOI: 10.1053/euhj.2000.2476
- 4Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877–883. DOI: 10.1056/NEJMoa013474
- 5Moss AJ, Hall JW, Cannom DS, Daubert JP. Improved Survival with An Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia. N Engl J Med. 2008; 335(26):1933–1940. DOI: 10.1056/NEJM199612263352601
- 6Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225–237. DOI: 10.1056/NEJMoa043399
- 7Lane RE, Cowie MR, Chow AWC. Prediction and prevention of sudden cardiac death in heart failure. Heart. 2005; 91(5):674–680. DOI: 10.1136/hrt.2003.025254
- 8Lyons KJ, Podder M, Ezekowitz JA. Rates and reasons for device-based guideline eligibility in patients with heart failure. Heart Rhythm. 2014; 11(11):1983–1990. DOI: 10.1016/j.hrthm.2014.08.004
- 9Mehra MR, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, et al. Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients. Pacing Clin Electrophysiol. 2012; 35(2):135–145. DOI: 10.1111/j.1540-8159.2011.03279.x
- 10Millar RNS, Mayosi BM. Utilization of implantable defibrillators in Africa. Card Electrophysiol Rev. 2003; 7(1):14–16. DOI: 10.1023/A:1023622502931
- 11Pillarisetti J, Emert M, Biria M, Chotia R, Guda MBBS R, Bommana MPhil S, et al. Under-Utilization of Implantable Cardioverter Defibrillators in Patients with Heart Failure-The Current State of Sudden Cardiac Death Prophylaxis. Indian Pacing Electrophysiol J. 2015; 15(1):20–29. DOI: 10.1016/S0972-6292(16)30838-5
- 12Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary. Circulation 2018; 138(13):210–271. DOI: 10.1016/j.hrthm.2017.10.035
- 13Varwani Mohamed Hasham. ICD implantation in post MI LV dysfunction: A sub Saharan Centre Experience. Cardiovasc J Afr. 2018; 29(3):12–15.
- 14Bernier R, Ng J, Tran DT, Lockwood E, Reyes L, Cowan K, et al. A Population-Based Study of Device Eligibility, Use, and Reasons for Nonimplantation in Patients at Heart Function Clinics. CJC Open. 2019; 1(4):173–81. DOI: 10.1016/j.cjco.2019.05.002
- 15Zhang L, Narayanan K, Chugh H, Shiota T, Zheng ZJ, Chugh SS. Factors influencing utilization of the primary prevention implantable defibrillator. PLoS One. 2015; 10(3):0121515. DOI: 10.1371/journal.pone.0121515
- 16Allen LaPointe NM, Al-Khatib SM, Piccini JP, Atwater BD, Honeycutt E, Thomas K, et al. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circ Cardiovasc Qual Outcomes. 2011; 4(2):146–51. DOI: 10.1161/CIRCOUTCOMES.110.958603
- 17Hess PL, Hernandez AF, Bhatt DL, Hellkamp AS, Yancy CW, Schwamm LH, et al. Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use among Patients Hospitalized with Heart Failure: Findings from the Get with the Guidelines-Heart Failure Program. Circulation. 2016; 134(7):517–526. DOI: 10.1161/CIRCULATIONAHA.115.021048
- 18Parkash R, Wightman H, Miles G, Sapp JL, Gardner M, Gray C, et al. Primary Prevention of Sudden Cardiac Death with Device Therapy in Urban and Rural Populations. Can J Cardiol. 2017; 33(4):437–442. DOI: 10.1016/j.cjca.2016.10.020
- 19Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007; 298(13):1517–1524. DOI: 10.1001/jama.298.13.1517
- 20Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, et al. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. EP Europace. 2014; 16(8):1175–1180. DOI: 10.1093/europace/euu015
- 21Lee JH, Yu HT, Oh IY, Choi EK, Sung JH, Lee YS, et al. Clinical and Hospital Factors Affecting Treatment with Primary Prevention Implantable Cardioverter-Defibrillators in Ischemic Cardiomyopathy Patients. Yonsei Med J. 2020; 61(11):942–950. DOI: 10.3349/ymj.2020.61.11.942
- 22Sadarmin PP, Wong KC, Rajappan K, Bashir Y, Betts TR. Barriers to patients eligible for screening investigations and insertion of primary prevention implantable cardioverter defibrillators. Europace. 2014; 16(11):1575–1579. DOI: 10.1093/europace/euu054
- 23Gupta A, Gholami P, Turakhia MP, Friday K, Heidenreich PA. Clinical reminders to providers of patients with reduced left ventricular ejection fraction increase defibrillator referral: A randomized trial. Circ Heart Fail. 2014; 7(1):140–145. DOI: 10.1161/CIRCHEARTFAILURE.113.000753
- 24Singh B, Zhang S, Ching CK, Huang D, Liu YB, Rodriguez DA, et al. Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal. Pacing Clin Electrophysiol. 2018; 41(12):1619–1626. DOI: 10.1111/pace.13526
- 25Bonny A, Ngantcha M, Jeilan M, Okello E, Kaviraj B, Talle MA, et al. Statistics on the use of cardiac electronic devices and interventional electrophysiological procedures in Africa from 2011 to 2016: Report of the Pan African Society of Cardiology (PASCAR) Cardiac Arrhythmias and Pacing Task Forces. Europace. 2018; 20(9):1513–1526. DOI: 10.1093/europace/eux353